A i in 2 sample taken from a general practice of 2,800 was studied to ascertain the prevalence of hyperlipidaemia, hypertension, and smoking, all shown by prospective studies to be risk factors in coronary disease. A lipoprotein analysis by membrane filtration and nephelometry was performed on all subjects. The male subjects of this samplefrom the age group 30 to 69 years have been compared with a group ofpatients with known ischaemic heart disease, matchedfor age and sex and investigated in an identical way. The prevalence of all three factors was greater in the ischaemic heart disease group but was statistically significant for hyperlipidaemia and smoking only. The prevalence of riskfactors taken in isolation or in combination when uninfluenced by the factors is shown. The prevalence of the combination of hyperlipoproteinaemia and hypertension when they are uninfluenced by smoking shows no correlation with ischaemic heart disease. When smoking is added to either hypertension or hyperlipoproteinaemia there is a significant relation with ischaemic heart disease.
A coronary risk factor has been defined by the American Heart Association as 'a finding associated with at least doubling of the risk' (Stamler et al., I969) . Though the aetiology of coronary disease has not been precisely established, much work has been done on risk factors in prospective studies (Stamler et al., I969; Dawber et al., I962; Doyle et al., I959; Keys et al., I963; Morris et al., I966; Tibblin, 1970) , mainly in the U.S.A. It has been reported that retrospective prevalence studies show similar findings (Friedman et al., I966; Medalie et al., I968; Mulcahy, Hickey, and Maurer, I969) . Since the incidence of coronary heart disease varies between countries (American Heart Association, I970), we have investigated the prevalence of hyperlipoproteinaemia, hypertension, and smoking, the 'cardinal' coronary risk factors (Stamler, I971) , in a random sample of subjects taken from one general practice, and have similarly investigated a group of patients with known ischaemic heart disease. Our results differ in certain respects from those previously reported, and have a bearing on the suggestion by Stamler et peutic trials. We feel it is pertinent to report our findings for the factors hyperlipoproteinaemia, diastolic hypertension, and smoking in the male groups 30 to 69 years.
Subjects
The subjects of this investigation were inhabitants of Leigh, an industrial town of 46,ooo people with a hospital catchment of nearly ioo,ooo. It is a relatively static population concerned mainly with the manufacture of cotton, artificial fibres, and electrical cable; in addition, there is some coal-mining, general engineering, and agriculture. There were two groups of subjects. a) Random sample of 283 men The random sample was a i in 2 selection made by M.C.S. from his general practice records. It was confined to subjects over the age of I5 years and included 480 men and 534 women. This report is confined to the 283 men aged 30 to 69 years (88% of 322 male subjects in this age group). They are referred to as the 'random sample'.
This group contained 26 subjects (9 2%) known to have ischaemic heart disease; 8 subjects (2 8%) group.bmj.com on April 7, 2017 -Published by http://heart.bmj.com/ Downloaded from where the two groups 'random sample' and 'ischaemic heart disease' are compared in decades of age. In every decade (30 to 69 year age range) there is a greater prevalence of all three risk factors in the ischaemic heart disease group, except for hypertension in the 60 to 69 decade. Though this increase in prevalence is not always statistically significant, it is significant in the total 30 to 69 group both for hyperlipoproteinaemia (P <o-ooi) and smoking (P < o os). There is a steady rise in the prevalence of hypertension with age in both groups until the age of 60; before that diastolic hypertension is more prevalent in every decade in the ischaemic heart disease group, but is not statistically significant at the 5 per cent level.
Prevalence of each factor in absence of other two In Table 2 we show in age groups 30 to 49, 50 to 69, 30 to 69 the numbers and percentage prevalence for hyperlipoproteinaemia, smoking, and diastolic blood pressure where they occur alone as the only one of these three factors in these subjects. There is a significant increase of prevalence in the ischaemic heart disease group for hyperlipoproteinaemia only. If we separate each factor in this way, the numbers are inevitably small, too small in the main to permit the use of x2 if the results are given in decades.
Prevalence of two factors in absence of third (Table 3) In Table 3 , two factors are combined in such a way that in each group the third factor is not present. In the 30 to 49 year group smoking combined with hyperlipoproteinaemia (P < o-oi), and smoking with diastolic hypertension (P <0o05) both show a significant increase in prevalence in the ischaemic heart disease group. However, when hyperlipoproteinaemia and diastolic hypertension are present and smoking is absent the percentage prevalence is virtually the same for both samples in all age groups. Prevalence of risk factors in any combination (Table 4)   Table 4 shows the prevalence for both 'random' and ischaemic heart disease groups, where there is any multiple of the three risk factors. The absence of factors shows a statistically significant negative relation with ischaemic heart disease in all three age groups. For the total age range this relation is significant at P < o-ooi level. When any one factor is present alone, there appears to be no difference in prevalence between the 'random sample' and 'ischaemic heart disease' groups. With the addition of another factor, the prevalence in the younger subjects is significantly greater in the ischaemic heart disease group (P < o-ooi level). The presence of all three factors together in one subject would be expected to show a closer relation with coronary disease. Discussion It should be noted that our 'random sample' did contain 38 cases that we regarded as having ischaemic heart disease, and therefore any statistical relation seems to us to err on the side of caution, in associating the prevalence of the three risk factors (hyperlipidaemia, smoking, and diastolic hypertension) with coronary disease.
Our results in Table i show that the prevalence of hyperlipoproteinaemia and smoking IS or more cigarettes a day is significantly greater in the 'ischaemic heart disease' group and therefore appears to support the claim that they are risk factors, as shown by prospective studies (Dawber et al., I962) . The prevalence of diastolic hypertension is similar in the two groups, but requires further comment as it is higher in the 'random' group than would be expected from published data (Hamilton et al., 1954 ; Report of Inter-Society Commission for Heart Disease Resources, I970), or from our own semibasal levels (T. B. S. Dick and M. C. Stone, I972, unpublished data). As previously mentioned, the diastolic pressure was the first reading taken at the first interview in the lying position after a brief rest. Though this standardized procedure resulted in a relatively high prevalence of diastolic hypertension, it in no way invalidates the comparison between the groups. In addition, the conditions under which these measurements were made are similar to those encountered in the average medical outpatient clinic. The difficulty of assessing the blood pressure level as between examiners and between countries has recently been stressed (American Heart Association Monograph, 1970).
Prospective studies have shown hyperlipidaemia, hypertension, and smoking to be 'risk factors', but which now related significantly to ischaemic heart group.bmj.com on April 7, 2017 -Published by http://heart.bmj.com/ Downloaded from disease was hyperlipoproteinaemia, but smoking in particular did not. When, however, we examined a combination of these risk factors occurring in the same subject, a greater prevalence in the 'ischaemic heart disease' group was found, except when hyperlipoproteinaemia was combined with hypertension and smoking was not present (Table 3 ). In this latter group there was no correlation with ischaemic heart disease; in fact the prevalence was virtually identical in the 'random' and 'ischaemic heart disease' groups for each age range. This does seem surprising when both hyperlipoproteinaemia and hypertension have been shown to be risk factors. We infer from our results that to report the prevalence of one factor without knowing the prevalence of other factors occurring in association with it can be misleading. Our findings in Table 3 suggest that smoking in the presence of hyperlipoproteinaemia or hypertension may take on a new importance which is not evident when smoking is the only factor present and is only partially evident when the total prevalence of smoking is reported.
The correction of cardinal risk factors as a preventive measure (Stamler, I971) may be justified, but the final evaluation of this must await the result of a prospective therapeutic trial. Our results, despite defects inherent in a retrospective study, and despite rather small numbers, do suggest that a cessation of smoking could be a major preventive measure, if either of the other two cardinal risk factors, namely hyperlipidaemia or hypertension, is present in the subject. 
